Literature DB >> 21797110

The effects of chronic losartan pretreatment on restraint stress-induced changes in motor activity, nociception and pentylenetetrazol generalized seizures in rats.

Daniela M Pechlivanova1, Alexander G Stoynev, Jana D Tchekalarova.   

Abstract

UNLABELLED: Accumulated evidence has shown that renin-angiotensin system has a pivotal role in stress responses. AIM: to assess the participation of AT1 receptor in stress-induced modulation of motor activity, nociception and seizure susceptibility in male Wistar rats.
MATERIAL AND METHODS: AT1 receptor antagonist losartan was administered subcutaneously to rats for 10 days at a dose of 10 mg/kg either alone or as a pretreatment before chronic restraint stress applied for 10 days. Locomotor and exploratory activity (open field test), the nociception (paw-pressure test) and the seizure susceptibility (pentylenetetrazol seizure test) were analysed.
RESULTS: Chronic restraint stress decreased motor activity and increased anxiety-like behaviour (grooming) while losartan pretreatment alleviated anxiety-like behaviour. Chronic restraint stress had an antinociceptive effect in paw-pressure test and losartan pretreatment abolished stress-induced antinociception. Both chronic restraint stress and losartan showed anticonvulsant activity in pentylenetetrazol seizure test. However, drug pretreatment attenuated this effect in chronically-stressed rats.
CONCLUSIONS: Our findings suggest that the AT1 receptor is involved in the mechanism of stress-induced changes in anxiety-like behaviour, nociception and seizure susceptibility in rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21797110     DOI: 10.2478/v10153-010-0040-z

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  5 in total

Review 1.  The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy.

Authors:  Natasha Ivanova; Jana Tchekalarova
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

2.  Protective effects of losartan on some type 2 diabetes mellitus-induced complications in Wistar and spontaneously hypertensive rats.

Authors:  Daniela Pechlivanova; Ekaterina Krumova; Nedelina Kostadinova; Jeny Mitreva-Staleva; Petar Grozdanov; Alexander Stoynev
Journal:  Metab Brain Dis       Date:  2020-01-29       Impact factor: 3.584

3.  Evaluation and comparison of anticonvulsant activity of telmisartan and olmesartan in experimentally induced animal models of epilepsy.

Authors:  Pushpa V H; Padmaja Shetty K; Suresha R N; Jayanthi M K; Ashwini V; Vaibhavi P S
Journal:  J Clin Diagn Res       Date:  2014-10-20

4.  Strain-dependent effects of sub-chronically infused losartan against kainic acid-induced seizures, oxidative stress, and heat shock protein 72 expression.

Authors:  Jane Tchekalarova; Natasha Ivanova; Daniela Pechlivanova; Kalina Ilieva; Milena Atanasova
Journal:  Cell Mol Neurobiol       Date:  2013-10-22       Impact factor: 5.046

5.  Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model.

Authors:  Hoda Ranjbar; Iraj Aghaei; Mahmood Moosazadeh; Mohammad Shabani
Journal:  Iran J Basic Med Sci       Date:  2018-08       Impact factor: 2.699

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.